IMR Press / RCM / Volume 5 / Issue 3 / pii/1561344972483-1219201866

Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on as a courtesy and upon agreement with MedReviews, LLC.

Open Access Review
Improving the Pharmacological Regimen for Patients With Diabetes Mellitus
Show Less
1 University of Missouri-Kansas City, Saint Luke's Hospital, Mid America Heart Institute, Kansas City, MO
Rev. Cardiovasc. Med. 2004, 5(3), 139–147;
Published: 30 September 2004
Type 2 diabetes mellitus afflicts nearly 17 million people in the United States, and prevalence rates are expected to double within 2 decades. Although there has been a downward trend in cardiovascular morbidity and mortality in recent years, cardiovascular disease remains the leading cause of death among patients with diabetes. This observation has led many to reevaluate current treatment goals and pharmacologic regimens for at-risk patients with type 2 diabetes mellitus. This review focuses on the current adjunctive pharmacologic treatment regimen that is well-suited for these patients.
Diabetes mellitus
Coronary artery disease
Myocardial infarction
Back to top